PRGX Global (PRGX) 10-Q12 May 142014 Q1 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
Document and Entity Information	Mar. 31, 2014	Apr. 25, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'PRGX GLOBAL, INC.	'
Entity Central Index Key	'0001007330	'
Document Type	'10-Q	'
Document Period End Date	31-Mar-14	'
Amendment Flag	'false	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	30,071,462

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Income Statement [Abstract]	'	'
Revenue	$37,901	$45,101
Operating expenses:	'	'
Cost of revenue	27,467	30,184
Selling, general and administrative expenses	11,341	11,934
Depreciation of property and equipment	1,682	2,008
Amortization of intangible assets	903	1,276
Total operating expenses	41,393	45,402
Operating loss	-3,492	-301
Foreign currency transaction (gains) losses on short-term intercompany balances	15	357
Interest expense (income), net	54	-217
Loss before income taxes	-3,561	-441
Income tax expense	113	56
Net loss	($3,674)	($497)
Basic earnings (loss) per common share (Note B) (usd per share)	($0.12)	($0.02)
Diluted earnings (loss) per common share (Note B) (usd per share)	($0.12)	($0.02)
Weighted-average common shares outstanding (Note B):	'	'
Basic (shares)	30,159	28,770
Diluted (shares)	30,159	28,770

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]	'	'
Net loss	($3,674)	($497)
Foreign currency translation adjustments	-70	-484
Comprehensive loss	($3,744)	($981)

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Current assets:	'	'
Cash and cash equivalents (Note E)	$45,697	$43,700
Restricted cash	126	57
Contract receivables, less allowances of $1,924 in 2014 and $1,996 in 2013:	'	'
Billed	25,121	28,175
Unbilled	6,290	9,904
Receivables Net	31,411	38,079
Employee advances and miscellaneous receivables, less allowances of $294 in 2014 and $402 in 2013	1,703	2,242
Total receivables	33,114	40,321
Prepaid expenses and other current assets	3,814	3,917
Total current assets	82,751	87,995
Property and equipment	55,146	58,796
Less accumulated depreciation and amortization	-41,956	-44,802
Property and equipment, net	13,190	13,994
Goodwill	13,691	13,686
Intangible assets, less accumulated amortization of $33,669 in 2014 and $32,717 in 2013	12,693	13,582
Noncurrent portion of unbilled receivables	816	1,379
Other assets	2,253	2,193
Total assets	125,394	132,829
Current liabilities:	'	'
Accounts payable and accrued expenses	7,640	10,809
Accrued payroll and related expenses	13,991	15,415
Refund liabilities	6,053	6,597
Deferred revenue	1,822	1,512
Business acquisition obligations	0	3,156
Total current liabilities	29,506	37,489
Noncurrent refund liabilities	847	950
Other long-term liabilities	574	562
Total liabilities	30,927	39,001
Commitments and contingencies (Note H)	'	'
Shareholdersâ€™ equity (Note B):	'	'
Common stock, no par value; $.01 stated value per share. Authorized 50,000,000 shares; 30,093,546 shares issued and outstanding as of March 31, 2014 and 29,367,439 shares issued and outstanding as of December 31, 2013	301	294
Additional paid-in capital	609,182	604,806
Accumulated deficit	-517,060	-513,386
Accumulated other comprehensive income	2,044	2,114
Total shareholdersâ€™ equity	94,467	93,828
Total liabilities and shareholders' equity	$125,394	$132,829

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]	'	'
Allowances for contract receivables	$1,924	$1,996
Allowances for employee advances and miscellaneous receivables	294	402
Accumulated amortization on intangible assets	$33,669	$32,717
Common stock, par value (usd per share)	$0	$0
Common stock, stated value per share (usd per share)	$0.01	$0.01
Common stock, shares authorized (shares)	50,000,000	50,000,000
Common stock, shares issued (shares)	30,093,546	29,367,439
Common stock, shares outstanding (shares)	30,093,546	29,367,439

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:	'	'
Net loss	($3,674)	($497)
Adjustments to reconcile net loss to net cash provided by operating activities:	'	'
Depreciation and amortization	2,585	3,284
Amortization of deferred loan costs	16	46
Stock-based compensation expense	1,021	1,318
Deferred income taxes	-209	-45
Foreign currency transaction (gains) losses on short-term intercompany balances	15	357
Changes in operating assets and liabilities:	'	'
Restricted cash	-69	-64
Billed receivables	3,055	5,163
Unbilled receivables	4,177	1,507
Prepaid expenses and other current assets	706	-313
Other assets	1	20
Accounts payable and accrued expenses	-3,192	-2,359
Accrued payroll and related expenses	-1,453	-6,985
Refund liabilities	-647	-273
Deferred revenue	309	279
Noncurrent compensation obligations	184	197
Other long-term liabilities	87	-786
Net cash provided by operating activities	2,912	849
Cash flows from investing activities:	'	'
Purchases of property and equipment, net of disposal proceeds	-844	-2,207
Net cash used in investing activities	-844	-2,207
Cash flows from financing activities:	'	'
Repayments of long-term debt	0	-750
Payment of deferred loan costs	-80	0
Restricted stock repurchased from employees for withholding taxes	-5	-430
Proceeds from option exercises	2,183	336
Payments of deferred acquisition consideration	-1,978	-1,656
Net proceeds from issuance of common stock	0	4,118
Repurchase of common stock	-40	0
Net cash provided by financing activities	80	1,618
Effect of exchange rates on cash and cash equivalents	-151	-279
Net increase (decrease) in cash and cash equivalents	1,997	-19
Cash and cash equivalents at beginning of period	43,700	37,806
Cash and cash equivalents at end of period	45,697	37,787
Supplemental disclosure of cash flow information:	'	'
Cash paid during the period for interest	19	71
Cash paid during the period for income taxes, net of refunds received	$948	$294

Basis_of_Presentation

Basis of Presentation	3 Months Ended
Basis of Presentation	Mar. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Basis of Presentation and Significant Accounting Policies [Text Block]	'
	Basis of Presentation
	The accompanying Condensed Consolidated Financial Statements (Unaudited) of PRGX Global, Inc. and its wholly owned subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three-month period ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014.
	Except as otherwise indicated or unless the context otherwise requires, “PRGX,” “we,” “us,” “our” and the “Company” refer to PRGX Global, Inc. and its subsidiaries. For further information, refer to the Consolidated Financial Statements and Footnotes thereto included in the Company’s Form 10-K for the year ended December 31, 2013.
	Beginning with the first quarter of 2014, we present the former New Services segment as two separate segments: Adjacent Services, which were formerly referred to as Profit Optimization services, and Healthcare Claims Recovery Audit Services. We have revised the presentation of our operating segments and related information in Note D - Operating Segments and Related Information.
	Beginning with the third quarter of 2013, we present fair value adjustments to acquisition-related contingent consideration as an adjustment to our segment measure—earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA") as presented in Note D - Operating Segments and Related Information. We now include these fair value adjustments in the Adjusted EBITDA calculation in the "Acquisition-related charges (benefits)" line, which we renamed from "Acquisition transaction costs and acquisition obligations classified as compensation." Accordingly, we have revised the presentation of our Adjusted EBITDA calculation for all relevant prior periods.
	Unbilled Receivables
	A significant portion of the unbilled receivables presented in the Condensed Consolidated Balance Sheets (Unaudited) relate to our Healthcare Claims Recovery Audit Services as we generally cannot invoice the prime contractors for whom we operate as a subcontractor under the Medicare RAC program until cash is collected by the prime contractors. These unbilled receivables, net of the related reserves, were $3.5 million and $5.6 million as of March 31, 2014 and December 31, 2013, respectively. As of May 2, 2014, we billed $2.5 million of the unbilled receivables relating to the Medicare RAC program that were outstanding as of March 31, 2014.
	New Accounting Standards
	A summary of the new accounting standard issued by the Financial Accounting Standards Board (“FASB”) and included in the Accounting Standards Codification (“ASC”) that applies to PRGX is set forth below:
	FASB ASC Update No. 2014-08. In April 2014, the FASB issued Accounting Standards Update No. 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360)—Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (“ASU 2014-08”). ASU 2014-08 raises the threshold for a disposal to qualify as a discontinued operation and requires new disclosures of both discontinued operations and certain other disposals that do not meet the definition of a discontinued operation. ASU 2014-08 is effective for annual periods beginning on or after December 15, 2014. We do not expect the adoption of ASU No. 2014-08 to have a material impact on our consolidated results of operations, financial position or cash flows.

Earnings_Per_Common_Share

Earnings Per Common Share	3 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Earnings (Loss) Per Common Share	'
	Earnings (Loss) Per Common Share
	The following tables set forth the computations of basic and diluted earnings (loss) per common share for the three months ended March 31, 2014 and 2013 (in thousands, except per share data):



		Three Months Ended March 31,
	Basic earnings (loss) per common share:	2014			2013
	Numerator:
	Net loss	$	(3,674	)	$	(497	)

	Denominator:
	Weighted-average common shares outstanding	30,159			28,770


	Basic earnings (loss) per common share	$	(0.12	)	$	(0.02	)



		Three Months Ended March 31,
	Diluted earnings (loss) per common share:	2014			2013
	Numerator:
	Net loss	$	(3,674	)	$	(497	)

	Denominator:
	Weighted-average common shares outstanding	30,159			28,770

	Incremental shares from stock-based compensation plans	—			—

	Denominator for diluted earnings (loss) per common share	30,159			28,770


	Diluted earnings (loss) per common share	$	(0.12	)	$	(0.02	)
	Weighted-average shares outstanding excludes antidilutive shares underlying options that totaled 2.4 million shares and antidilutive Performance Units issuable under the Company's 2006 Management Incentive Plan that totaled less than 0.1 million shares from the computation of diluted earnings (loss) per common share for the three months ended March 31, 2014. Weighted-average shares outstanding excludes antidilutive shares underlying options that totaled 2.9 million shares and anti-dilutive Performance Units related to the Company's 2006 Management Incentive Plan that totaled 0.1 million from the computation of diluted earnings (loss) per common share for the three months ended March 31, 2013. As a result of the net loss for the three months ended March 31, 2014 and March 31, 2013, all shares underlying stock options and Performance Units were considered antidilutive. The number of common shares we used in the basic and diluted earnings (loss) per common share computations include nonvested restricted shares of 0.7 million and 0.8 million for the three months ended March 31, 2014 and 2013, respectively, and nonvested restricted share units that we consider to be participating securities of 0.2 million for both the three months ended March 31, 2014 and 2013.
	On December 11, 2012, we closed a public offering of 6,249,234 shares of our common stock, which consisted of 2,500,000 shares sold by us and 3,749,234 shares sold by certain selling shareholders, at a price to the public of $6.39 per share. The net proceeds to us from the public offering, after deducting underwriting discounts and commissions and offering expenses, were $14.7 million. We did not receive any proceeds from the sale of shares by the selling shareholders. In addition, the underwriters elected to exercise an overallotment option for an additional 687,385 shares, and completed the additional sale on January 8, 2013. The net proceeds to us from the overallotment, after deducting underwriting discounts and commission and offering expenses, were $4.1 million.
	In partial satisfaction of a business acquisition obligation, we issued 187,620 shares of our common stock having a value of $1.3 million in the three months ended March 31, 2014 and 217,155 shares of our common stock having a value of $1.4 million in the three months ended March 31, 2013.

StockBased_Compensation

Stock-Based Compensation	3 Months Ended
	Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Stock-Based Compensation	'
	Stock-Based Compensation
	The Company currently has three stock-based compensation plans under which awards have been granted: (1) the Stock Incentive Plan; (2) the 2006 Management Incentive Plan (“2006 MIP”); and (3) the 2008 Equity Incentive Plan (“2008 EIP”) (collectively, the “Plans”). We describe the Plans in the Company’s Annual Report on Form 10–K for the fiscal year ended December 31, 2013.
	2008 EIP Awards
	Stock options granted under the 2008 EIP generally have a term of seven years and vest in equal annual increments over the vesting period, which typically is three years for employees and one year for directors. There were no stock option grants during the three months ended March 31, 2014. The following table summarizes stock option grants during the three months ended March 31, 2013:


	Grantee		# of	Vesting Period	Weighted		Weighted
	Type		Options		Average		Average Grant
			Granted		Exercise Price		Date Fair Value
	2013
	Director group		7,122	1 year or less	$	6.83	$	2.35

	Director group		17,092	3 years	$	6.83	$	3.76

	Employee group		5,000	3 years	$	6.83	$	3.65

	Employee inducement (1)		20,000	3 years	$	7.14	$	3.81



	-1	The Company granted non-qualified performance-based stock options outside its existing stock-based compensation plans in the first quarter of 2013 to one employee in connection with the employee joining the Company.
	Nonvested stock awards, including both restricted stock and restricted stock units, generally are nontransferable until vesting and the holders are entitled to receive dividends with respect to the nonvested shares. Prior to vesting, the grantees of restricted stock are entitled to vote the shares, but the grantees of restricted stock units are not entitled to vote the shares. Generally, nonvested stock awards vest in equal annual increments over the vesting period, which typically is three years for employees and one year for directors. There were no nonvested stock awards (restricted stock and restricted stock units) granted during the three months ended March 31, 2014. The following table summarizes nonvested stock awards granted during the three months ended March 31, 2013:



	Grantee		# of Shares	Vesting Period	Weighted
	Type		Granted		Average Grant
					Date Fair Value
	2013
	Director group		7,122	1 year or less	$	6.83

	Director group		17,092	3 years	$	6.83

	Employee group		5,000	3 years	$	6.83

	Employee inducement (1)		20,000	3 years	$	7.14



	-1	The Company granted nonvested performance-based stock awards (restricted stock) outside its existing stock-based compensation plans in the first quarter of 2013 to one employee in connection with the employee joining the Company.
	2006 MIP Performance Units
	On June 19, 2012, seven senior officers of the Company were granted 154,264 Performance Units under the 2006 MIP, comprising all remaining available awards under the 2006 MIP. The awards had an aggregate grant date fair value of $1.2 million and vest ratably over three years. Upon vesting, the Performance Units will be settled by the issuance of Company common stock equal to 60% of the number of Performance Units being settled and the payment of cash in an amount equal to 40% of the fair market value of that number of shares of common stock equal to the number of Performance Units being settled. During 2013, an aggregate of 93,664 Performance Units were settled by four current executive officers and two former executive officers, and 16,524 Performance Units were forfeited by one former executive officer. Such settlements resulted in the issuance of 56,197 shares of common stock and cash payments totaling $0.2 million. As of March 31, 2014, a total of 44,076 Performance Units were outstanding, none of which were vested. There was no settlement of Performance Units during the three months ended March 31, 2014.
	Selling, general and administrative expenses for the three months ended March 31, 2014 and 2013 include $1.0 million and $1.3 million, respectively, related to stock-based compensation charges. At March 31, 2014, there was $5.5 million of unrecognized stock-based compensation expense related to stock options, restricted stock awards, restricted stock unit awards, and Performance Unit awards which we expect to recognize over a weighted-average period of 1.7 years.

Operating_Segments_and_Related

Operating Segments and Related Information	3 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
Operating Segments and Related Information	'
	Operating Segments and Related Information
	Beginning with the first quarter of 2014, we present the former New Services segment as two separate segments: Adjacent Services, which were formerly referred to as Profit Optimization services, and Healthcare Claims Recovery Audit Services. We now conduct our operations through the following four reportable segments:
	Recovery Audit Services – Americas represents recovery audit services (other than Healthcare Claims Recovery Audit services) provided in the United States of America (“U.S.”), Canada and Latin America.
	Recovery Audit Services – Europe/Asia-Pacific represents recovery audit services (other than Healthcare Claims Recovery Audit services) provided in Europe, Asia and the Pacific region.
	Adjacent Services (formerly known as Profit Optimization services) represents data transformation and financial advisory services.
	Healthcare Claims Recovery Audit Services represents recovery audit services for healthcare claims, which consist primarily of services provided under subcontracts related to the Medicare Recovery Audit Contractor program.
	Additionally, *Corporate Support* includes the unallocated portion of corporate selling, general and administrative expenses not specifically attributable to the four reportable segments.
	We evaluate the performance of our reportable segments based upon revenue and measures of profit or loss we refer to as EBITDA and Adjusted EBITDA. We define Adjusted EBITDA as earnings from continuing operations before interest and taxes (“EBIT”), adjusted for depreciation and amortization (“EBITDA”), and then further adjusted for unusual and other significant items that management views as distorting the operating results of the various segments from period to period. Such adjustments include restructuring charges, stock-based compensation, bargain purchase gains, acquisition-related charges and benefits (acquisition transaction costs, acquisition obligations classified as compensation, and fair value adjustments to acquisition-related contingent consideration), tangible and intangible asset impairment charges, certain litigation costs and litigation settlements, certain severance charges and foreign currency transaction gains and losses on short-term intercompany balances viewed by management as individually or collectively significant. We do not have any inter-segment revenue.
	Segment information for the three months ended March 31, 2013 has been revised to reflect the change in reportable segments. Segment information for the three months ended March 31, 2014 and 2013 (in thousands) is as follows:



			Recovery			Recovery Audit				Adjacent				Healthcare Claims Recovery Audit Services				Corporate				Total
			Audit			Services –				Services								Support
			Services –			Europe/Asia-
			Americas			Pacific
	Three Months Ended March 31, 2014
	Revenue		$	24,798		$	9,702			$	2,283			$	1,118			$	—			$	37,901


	Net loss																					$	(3,674	)
	Income tax expense																					113

	Interest expense, net																					54

	EBIT		$	4,084		$	101			$	(1,574	)		$	(2,006	)		$	(4,112	)		(3,507		)

	Depreciation of property and equipment		1,256			146				160				120				—				1,682

	Amortization of intangible assets		500			307				96				—				—				903

	EBITDA		5,840			554				(1,318		)		(1,886		)		(4,112		)		(922		)

	Foreign currency transaction (gains) losses on short-term intercompany balances		110			(73		)		—				—				(22		)		15

	Acquisition-related charges		—			—				19				—				—				19

	Transformation severance and related expenses		8			79				143				155				—				385

	Stock-based compensation		—			—				—				—				1,021				1,021

	Adjusted EBITDA		$	5,958		$	560			$	(1,156	)		$	(1,731	)		$	(3,113	)		$	518




			Recovery			Recovery Audit				Adjacent				Healthcare Claims Recovery Audit Services				Corporate				Total
			Audit			Services –				Services								Support
			Services –			Europe/Asia-
			Americas			Pacific
	Three Months Ended March 31, 2013
	Revenue		$	26,242		$	11,017			$	3,943			$	3,899			$	—			$	45,101


	Net loss																					$	(497	)
	Income tax expense																					56

	Interest income, net																					(217		)
	EBIT		$	5,454		$	441			$	(311	)		$	(850	)		$	(5,392	)		(658		)

	Depreciation of property and equipment		1,368			112				155				373				—				2,008

	Amortization of intangible assets		698			396				182				—				—				1,276

EBITDA		7,520			949				26				(477		)		(5,392		)		2,626

Foreign currency transaction (gains) losses on short-term intercompany balances		52			306				—				—				(1		)		357

Acquisition-related charges (benefits)		10			(732		)		56				—				—				(666		)

Stock-based compensation		—			—				—				—				1,318				1,318

Adjusted EBITDA		$	7,582		$	523			$	82			$	(477	)		$	(4,075	)		$	3,635

Cash_and_Cash_Equivalents

Cash and Cash Equivalents	3 Months Ended
Cash and Cash Equivalents	Mar. 31, 2014
Cash and Cash Equivalents [Abstract]	'
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	Cash and cash equivalents include all cash balances and highly liquid investments with an initial maturity of three months or less from date of purchase. We place our temporary cash investments with high credit quality financial institutions. At times, certain investments may be in excess of the Federal Deposit Insurance Corporation (“FDIC”) insurance limit or otherwise may not be covered by FDIC insurance. Some of our cash and cash equivalents are held at banks in jurisdictions outside the U.S. that have restrictions on transferring such assets outside of these countries on a temporary or permanent basis. Such restricted net assets are not significant in comparison to our consolidated net assets.
	Our cash and cash equivalents included short-term investments of approximately $25.6 million as of March 31, 2014 and $24.6 million as of December 31, 2013, of which approximately $4.8 million and $4.4 million, respectively, were held at banks outside of the United States, primarily in Brazil and Canada.

Debt

Debt	3 Months Ended
Debt	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Debt	'
	Debt
	On January 19, 2010, we entered into a four-year revolving credit and term loan agreement with SunTrust Bank (“SunTrust”). The SunTrust credit facility initially consisted of a $15.0 million committed revolving credit facility and a $15.0 million term loan. The SunTrust term loan required quarterly principal payments of $0.8 million beginning in March 2010, and a final principal payment of $3.0 million due in January 2014 that we paid in December 2013. The SunTrust credit facility is guaranteed by the Company and all of its material domestic subsidiaries and secured by substantially all of the assets of the Company.
	On January 17, 2014, we entered into an amendment of the SunTrust credit facility that increased the committed revolving credit facility from $15.0 million to $25.0 million, lowered the applicable margin to a fixed rate of 1.75%, eliminated the provision limiting availability under the revolving credit facility based on eligible accounts receivable and extended the scheduled maturity of the revolving credit facility to January 16, 2015 (subject to earlier termination as provided therein). As of March 31, 2014, we had no outstanding borrowings under the SunTrust revolver. With the provision of a fixed applicable margin of 1.75% per the amendment of the SunTrust credit facility, the interest rate that would have applied at March 31, 2014 had any borrowings been outstanding was approximately 1.90%. We also must pay a commitment fee of 0.5% per annum, payable quarterly, on the unused portion of the $25.0 million SunTrust revolving credit facility.
	Prior to the January 2014 amendment to the SunTrust credit facility, amounts available under the SunTrust revolver were based on eligible accounts receivable and other factors. Interest on both the revolver and term loan was payable monthly and accrued at an index rate using the one-month LIBOR rate, plus an applicable margin as determined by the loan agreement. The applicable interest rate margin varied from 2.25% per annum to 3.5% per annum, dependent on our consolidated leverage ratio, and was determined in accordance with a pricing grid under the SunTrust loan agreement.
	The SunTrust credit facility requires, as of the end of each fiscal quarter, the Company to have achieved Consolidated Adjusted EBITDA (as defined in the agreement) of at least $22.5 million for the immediately preceding four quarters. As of March 31, 2014, the Company's Consolidated Adjusted EBITDA for the preceding four quarters was $22.2 million, and therefore the Company was not in compliance with the covenant, although there were no amounts outstanding under the credit facility as of that date. On May 8, 2014, the Company entered into an amendment of the SunTrust credit facility that provided a waiver of the non-compliance with the minimum Consolidated Adjusted EBITDA covenant for the quarter ended March 31, 2014 and reduced the minimum Consolidated Adjusted EBITDA requirement to $18.0 million. The amendment also authorized a $10.0 million increase to the Company's stock repurchase program, bringing the total amount of its common stock that the Company may repurchase under the program to $20.0 million.

Fair_Value_of_Financial_Instru

Fair Value of Financial Instruments	3 Months Ended
Fair Value of Financial Instruments	Mar. 31, 2014
Fair Value Disclosures [Abstract]	'
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	We state cash equivalents at cost, which approximates fair market value. The carrying values for receivables from clients, unbilled services, accounts payable, deferred revenue and other accrued liabilities reasonably approximate fair market value due to the nature of the financial instrument and the short term maturity of these items.
	We repaid the remaining balance of our bank debt in December 2013, and had no debt outstanding as of March 31, 2014. We consider the factors used in determining the fair value of debt to be Level 3 inputs (significant unobservable inputs).
	We had no business acquisition obligations as of March 31, 2014, and as of December 31, 2013 had $3.2 million of business acquisition obligations representing the fair value of deferred consideration and earn-out payments estimated to be due as of that date. We determine the estimated fair values based on our projections of future revenue and profits or other factors used in the calculation of the ultimate payment to be made. The discount rate that we use to value the liability is based on specific business risk, cost of capital, and other factors. We consider these factors to be Level 3 inputs (significant unobservable inputs).

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	Commitments and Contingencies
	Legal Proceedings
	We are party to a variety of legal proceedings arising in the normal course of business. While the results of these proceedings cannot be predicted with certainty, management believes that the final outcome of these proceedings will not have a material adverse effect on our financial position, results of operations or cash flows.

Income_Taxes

Income Taxes	3 Months Ended
Income Taxes	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Income Taxes
	Reported income tax expense in each period primarily results from taxes on the income of foreign subsidiaries. The effective tax rates generally differ from the expected tax rate due primarily to the Company’s deferred tax asset valuation allowance on the domestic earnings and taxes on income of foreign subsidiaries.
	In the three months ended March 31, 2013, we partially offset these foreign income taxes by reversing $0.4 million of accruals made in prior years for uncertain tax positions. Significant judgment is required in evaluating our uncertain tax positions and determining our provision for income taxes. In addition, we are subject to the continuous examination of our income tax returns by the Internal Revenue Service in the U.S. and other tax authorities. We regularly assess the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes.

Subsequent_Events

Subsequent Events	3 Months Ended
Subsequent Events	Mar. 31, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	Subsequent Events
	On May 8, 2014, the Company entered into an amendment of the SunTrust credit facility that provided a waiver of the non-compliance with the minimum Consolidated Adjusted EBITDA covenant for the quarter ended March 31, 2014, reduced the minimum Consolidated Adjusted EBITDA requirement to $18.0 million, and increased the total amount of common stock that the Company may repurchase under the stock repurchase program by $10.0 million to $20.0 million. Through May 9, 2014, the Company repurchased a total of 202,700 shares under this program through open-market transactions for an aggregate purchase price of $1.3 million.

Basis_of_Presentation_Policies

Basis of Presentation (Policies)	3 Months Ended
Basis of Presentation (Policies)	Mar. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Unbilled Receivables	'
	Unbilled Receivables
	A significant portion of the unbilled receivables presented in the Condensed Consolidated Balance Sheets (Unaudited) relate to our Healthcare Claims Recovery Audit Services as we generally cannot invoice the prime contractors for whom we operate as a subcontractor under the Medicare RAC program until cash is collected by the prime contractors. These unbilled receivables, net of the related reserves, were $3.5 million and $5.6 million as of March 31, 2014 and December 31, 2013, respectively. As of May 2, 2014, we billed $2.5 million of the unbilled receivables relating to the Medicare RAC program that were outstanding as of March 31, 2014.
New Accounting Standards	'
	New Accounting Standards
	A summary of the new accounting standard issued by the Financial Accounting Standards Board (“FASB”) and included in the Accounting Standards Codification (“ASC”) that applies to PRGX is set forth below:
	FASB ASC Update No. 2014-08. In April 2014, the FASB issued Accounting Standards Update No. 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360)—Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (“ASU 2014-08”). ASU 2014-08 raises the threshold for a disposal to qualify as a discontinued operation and requires new disclosures of both discontinued operations and certain other disposals that do not meet the definition of a discontinued operation. ASU 2014-08 is effective for annual periods beginning on or after December 15, 2014. We do not expect the adoption of ASU No. 2014-08 to have a material impact on our consolidated results of operations, financial position or cash flows.

Earnings_Per_Common_Share_Tabl

Earnings Per Common Share (Tables)	3 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Computations of basic and diluted earnings (loss) per common share	'
	The following tables set forth the computations of basic and diluted earnings (loss) per common share for the three months ended March 31, 2014 and 2013 (in thousands, except per share data):



		Three Months Ended March 31,
	Basic earnings (loss) per common share:	2014			2013
	Numerator:
	Net loss	$	(3,674	)	$	(497	)

	Denominator:
	Weighted-average common shares outstanding	30,159			28,770


	Basic earnings (loss) per common share	$	(0.12	)	$	(0.02	)



		Three Months Ended March 31,
	Diluted earnings (loss) per common share:	2014			2013
	Numerator:
	Net loss	$	(3,674	)	$	(497	)

	Denominator:
	Weighted-average common shares outstanding	30,159			28,770

	Incremental shares from stock-based compensation plans	—			—

	Denominator for diluted earnings (loss) per common share	30,159			28,770


	Diluted earnings (loss) per common share	$	(0.12	)	$	(0.02	)

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Summary of stock option grants	'
	The following table summarizes stock option grants during the three months ended March 31, 2013:


	Grantee		# of	Vesting Period	Weighted		Weighted
	Type		Options		Average		Average Grant
			Granted		Exercise Price		Date Fair Value
	2013
	Director group		7,122	1 year or less	$	6.83	$	2.35

	Director group		17,092	3 years	$	6.83	$	3.76

	Employee group		5,000	3 years	$	6.83	$	3.65

	Employee inducement (1)		20,000	3 years	$	7.14	$	3.81



	-1	The Company granted non-qualified performance-based stock options outside its existing stock-based compensation plans in the first quarter of 2013 to one employee in connection with the employee joining the Company.
Summary of nonvested stock awards granted	'
	The following table summarizes nonvested stock awards granted during the three months ended March 31, 2013:



	Grantee		# of Shares	Vesting Period	Weighted
	Type		Granted		Average Grant
					Date Fair Value
	2013
	Director group		7,122	1 year or less	$	6.83

	Director group		17,092	3 years	$	6.83

	Employee group		5,000	3 years	$	6.83

	Employee inducement (1)		20,000	3 years	$	7.14



	-1	The Company granted nonvested performance-based stock awards (restricted stock) outside its existing stock-based compensation plans in the first quarter of 2013 to one employee in connection with the employee joining the Company.

Operating_Segments_and_Related1

Operating Segments and Related Information (Tables)	3 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
Segment information	'
	Segment information for the three months ended March 31, 2013 has been revised to reflect the change in reportable segments. Segment information for the three months ended March 31, 2014 and 2013 (in thousands) is as follows:



			Recovery			Recovery Audit				Adjacent				Healthcare Claims Recovery Audit Services				Corporate				Total
			Audit			Services –				Services								Support
			Services –			Europe/Asia-
			Americas			Pacific
	Three Months Ended March 31, 2014
	Revenue		$	24,798		$	9,702			$	2,283			$	1,118			$	—			$	37,901


	Net loss																					$	(3,674	)
	Income tax expense																					113

	Interest expense, net																					54

	EBIT		$	4,084		$	101			$	(1,574	)		$	(2,006	)		$	(4,112	)		(3,507		)

	Depreciation of property and equipment		1,256			146				160				120				—				1,682

	Amortization of intangible assets		500			307				96				—				—				903

	EBITDA		5,840			554				(1,318		)		(1,886		)		(4,112		)		(922		)

	Foreign currency transaction (gains) losses on short-term intercompany balances		110			(73		)		—				—				(22		)		15

	Acquisition-related charges		—			—				19				—				—				19

	Transformation severance and related expenses		8			79				143				155				—				385

	Stock-based compensation		—			—				—				—				1,021				1,021

	Adjusted EBITDA		$	5,958		$	560			$	(1,156	)		$	(1,731	)		$	(3,113	)		$	518




			Recovery			Recovery Audit				Adjacent				Healthcare Claims Recovery Audit Services				Corporate				Total
			Audit			Services –				Services								Support
			Services –			Europe/Asia-
			Americas			Pacific
	Three Months Ended March 31, 2013
	Revenue		$	26,242		$	11,017			$	3,943			$	3,899			$	—			$	45,101


	Net loss																					$	(497	)
	Income tax expense																					56

	Interest income, net																					(217		)
	EBIT		$	5,454		$	441			$	(311	)		$	(850	)		$	(5,392	)		(658		)

	Depreciation of property and equipment		1,368			112				155				373				—				2,008

	Amortization of intangible assets		698			396				182				—				—				1,276

	EBITDA		7,520			949				26				(477		)		(5,392		)		2,626

	Foreign currency transaction (gains) losses on short-term intercompany balances		52			306				—				—				(1		)		357

	Acquisition-related charges (benefits)		10			(732		)		56				—				—				(666		)

	Stock-based compensation		—			—				—				—				1,318				1,318

Adjusted EBITDA		$	7,582		$	523			$	82			$	(477	)		$	(4,075	)		$	3,635

Basis_of_Presentation_Basis_of

Basis of Presentation Basis of Presentation (Details) (Medicare RAC [Member], USD $)	Mar. 31, 2014	Dec. 31, 2013	2-May-14
In Millions, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013	Subsequent event [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]	'	'	'
Accounts, Notes, Loans and Financing Receivable, Net, Current	$3.50	$5.60	'
Additional Billed Receivables Current	'	'	$2.50

Earnings_Per_Common_Share_Deta

Earnings Per Common Share (Details) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Numerator:	'	'
Net loss	($3,674)	($497)
Denominator:	'	'
Weighted-average common shares outstanding (shares)	30,159	28,770
Basic earnings (loss) per common share (usd per share)	($0.12)	($0.02)
Numerator:	'	'
Net loss	($3,674)	($497)
Denominator:	'	'
Weighted-average common shares outstanding (shares)	30,159	28,770
Incremental shares from stock-based compensation plans (shares)	0	0
Denominator for diluted earnings (loss) per common share (shares)	30,159	28,770
Diluted earnings (loss) per common share (usd per share)	($0.12)	($0.02)

Earnings_Per_Common_Share_Deta1

Earnings Per Common Share (Details Textual) (USD $)	0 Months Ended	1 Months Ended	3 Months Ended
Earnings Per Common Share (Details Textual) (USD $)	Jan. 08, 2013	Dec. 11, 2012	Mar. 31, 2014	Mar. 31, 2013
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share and Other Significant Changes in Shares [Line Items]	'	'	'	'
Number of common shares in the basic and diluted earnings per common share (shares)	'	'	700,000	800,000
Nonvested restricted share (shares)	'	'	200,000	200,000
Public offering common stock shares (shares)	'	6,249,234	'	'
Public offering by company (shares)	'	2,500,000	'	'
Public offering by selling shareholders (shares)	'	3,749,234	'	'
Public offering, price per share (usd per share)	'	$6.39	'	'
Public offering, net proceeds	$4,100,000	$14,700,000	$0	$4,118,000
Additional shares, overallotment option (shares)	687,385	'	'	'
Business Strategy, Inc. [Member]	'	'	'	'
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share and Other Significant Changes in Shares [Line Items]	'	'	'	'
Business combination, consideration paid in common stock, shares	'	'	187,620	217,155
Business combination, consideration paid in common stock, value	'	'	$1,300,000	$1,400,000
Non-qualified Option [Member]	'	'	'	'
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share and Other Significant Changes in Shares [Line Items]	'	'	'	'
Weighted average shares outstanding excludes anti-dilutive shares underlying options (shares) (less than 0.1 million)	'	'	2,400,000	2,900,000
Performance Unit [Member]	'	'	'	'
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share and Other Significant Changes in Shares [Line Items]	'	'	'	'
Weighted average shares outstanding excludes anti-dilutive shares underlying options (shares) (less than 0.1 million)	'	'	100,000	100,000
Antidilutive shares underlying options excluded from earnings (loss) per share	'	'	'less than 0.1 million	'

StockBased_Compensation_Detail

Stock-Based Compensation (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2013
	Director group [Member]	Director group [Member]	Director Group 1 [Member]	Employee [Member]	Employee [Member]	Employee inducement (1) [Member]
		2008 Equity Incentive Plan [Member]	2008 Equity Incentive Plan [Member]		2008 Equity Incentive Plan [Member]	2008 Equity Incentive Plan [Member]
Summary of stock option grants	'	'	'	'	'	'
Grantee Type	'	'Director group	'Director group	'	'Employee group	'Employee inducement (1)
No. of Options Granted (shares)	'	7,122	17,092	'	5,000	20,000	[1]
Vesting Period	'	'1Â yearÂ orÂ less	'	'	'	'
Vesting Period	'1 year	'	'3 years	'3 years	'3 years	'3 years	[1]
Weighted Average Exercise Price (usd per share)	'	$6.83	$6.83	'	$6.83	$7.14	[1]
Weighted Average Grant Date Fair Value (usd per share)	'	$2.35	$3.76	'	$3.65	$3.81	[1]

[1]	(1)The Company granted nonvested performance-based stock awards (restricted stock) outside its existing stock-based compensation plans in the first quarter of 2013 to one employee in connection with the employee joining the Company.

StockBased_Compensation_Detail1

Stock-Based Compensation (Details 1) (USD $)

3 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Director group [Member]

Employee [Member]

2008 Equity Incentive Plan [Member]

Restricted Stock and Restricted Stock Units [Member]

Director group [Member]

Director Group 1 [Member]

Employee [Member]

Employee inducement (1) [Member]

2008 Equity Incentive Plan [Member]

Director group [Member]

Director Group 1 [Member]

Employee [Member]

Employee inducement (1) [Member]

Summary of nonvested stock awards granted

Grantee Type

'Director group

'Employee group

'Employee inducement (1)

No. of Shares Granted (shares)

7,122

17,092

5,000

20,000

Vesting Period

'1Â yearÂ orÂ less

Vesting Period

'1 year

'3 years

[1]

'3 years

Weighted Average Grant Date Fair Value (usd per share)

$2.35

$3.76

$3.65

$3.81

[1]

$6.83

$7.14

[1]

(1)The Company granted nonvested performance-based stock awards (restricted stock) outside its existing stock-based compensation plans in the first quarter of 2013 to one employee in connection with the employee joining the Company.

StockBased_Compensation_Detail2

Stock-Based Compensation (Details Textual) (USD $)

3 Months Ended

1 Months Ended

3 Months Ended

In Millions, except Share data, unless otherwise specified

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Jun. 30, 2012

Mar. 31, 2014

Jun. 19, 2012

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

compensation_plan

The Plans [Member]

Employee Group [Member]

Director Group [Member]

Performance Shares [Member]

Restricted Stock and Restricted Stock Units [Member]

Stock Options [Member]

2008 Equity Incentive Plan [Member]

2006 Management Incentive Plan [Member]

2008 Equity Incentive Plan [Member]

Employee Group [Member]

Director [Member]

2008 Equity Incentive Plan [Member]

Director [Member]

executive_officer

2008 Equity Incentive Plan [Member]

Stock-Based Compensation (Textual) [Abstract]

Number of stock-based compensation plans

Stock options expiration period

'7 years

Stock options vesting period

'3 years

'1 year

'3 years

'1 year

'3 years

'1 year

Stock options award vesting right

'vest in equal annual increments over the vesting period

No. of Options Granted (shares)

5,000

7,122

Total of performance units were outstanding and fully vested (shares)

44,076

154,264

Grant date fair value awards

$1.20

Percentage of performance units (percent)

60.00%

Percentage of fair market value (percent)

40.00%

Performance units settled in period (shares)

93,664

Number of executive officers that settled performance units in period (executive officers)

Number of former executive officers that settled performance units in period (executive officers)

Performance units forfeited in period (shares)

16,524

Number of former executive officers that forfeited performance units in period (executive officer)

Common stock issued during period (shares)

56,197

Cash payments for shares settled during period

0.2

Selling, general and administrative expenses

1.3

Unrecognized stock-based compensation expense related to stock options

$5.50

Weighted-average period for recognizing stock compensation expense

'1 year 8 months 13 days

Operating_Segments_and_Related2

Operating Segments and Related Information (Details Textual)	3 Months Ended
	Mar. 31, 2014
	Segment
Segment Reporting Information [Line Items]	'
Number of reportable segments	4
New Services [Member]	'
Segment Reporting Information [Line Items]	'
Number of reportable segments	2

Operating_Segments_and_Related3

Operating Segments and Related Information (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Segment information	'	'
Revenue	$37,901	$45,101
Net loss	-3,674	-497
Income tax expense	113	56
Interest expense (income), net	54	-217
EBIT	-3,507	-658
Depreciation of property and equipment	1,682	2,008
Amortization of intangible assets	903	1,276
EBITDA	-922	2,626
Foreign currency transaction (gains) losses on short-term intercompany balances	15	357
Acquisition-related charges	19	-666
Transformation severance and related expenses	385	'
Stock-based compensation	1,021	1,318
Adjusted EBITDA	518	3,635
Recovery Audit Services - Americas [Member]	'	'
Segment information	'	'
Revenue	24,798	26,242
EBIT	4,084	5,454
Depreciation of property and equipment	1,256	1,368
Amortization of intangible assets	500	698
EBITDA	5,840	7,520
Foreign currency transaction (gains) losses on short-term intercompany balances	110	52
Acquisition-related charges	'	10
Transformation severance and related expenses	8	'
Adjusted EBITDA	5,958	7,582
Recovery Audit Services - Europe/Asia-Pacific [Member]	'	'
Segment information	'	'
Revenue	9,702	11,017
EBIT	101	441
Depreciation of property and equipment	146	112
Amortization of intangible assets	307	396
EBITDA	554	949
Foreign currency transaction (gains) losses on short-term intercompany balances	-73	306
Acquisition-related charges	'	-732
Transformation severance and related expenses	79	'
Adjusted EBITDA	560	523
Adjacent Services [Member]	'	'
Segment information	'	'
Revenue	2,283	3,943
EBIT	-1,574	-311
Depreciation of property and equipment	160	155
Amortization of intangible assets	96	182
EBITDA	-1,318	26
Acquisition-related charges	19	56
Transformation severance and related expenses	143	'
Adjusted EBITDA	-1,156	82
Healthcare Claims Recovery Audit Services [Member]	'	'
Segment information	'	'
Revenue	1,118	3,899
EBIT	-2,006	-850
Depreciation of property and equipment	120	373
EBITDA	-1,886	-477
Transformation severance and related expenses	155	'
Adjusted EBITDA	-1,731	-477
Corporate Support [Member]	'	'
Segment information	'	'
EBIT	-4,112	-5,392
EBITDA	-4,112	-5,392
Foreign currency transaction (gains) losses on short-term intercompany balances	-22	-1
Stock-based compensation	1,021	1,318
Adjusted EBITDA	($3,113)	($4,075)

Cash_and_Cash_Equivalents_Deta

Cash and Cash Equivalents (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Line of Credit Facility [Line Items]	'	'
Cash and cash equivalents included short-term investments	$25.60	$24.60
Foreign Banks [Member]	'	'
Line of Credit Facility [Line Items]	'	'
Cash and cash equivalents included short-term investments	$4.80	$4.40

Debt_Details_Textual

Debt (Details Textual) (USD $)

3 Months Ended

0 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

Mar. 31, 2014

Jan. 17, 2014

8-May-14

Mar. 31, 2014

Jan. 19, 2010

Mar. 31, 2014

Jan. 17, 2014

Jan. 19, 2010

8-May-14

Subsequent event [Member]

SunTrust Bank [Member]

Sun Trust Term Loan [Member]

Sun Trust Revolving Credit Facility [Member]

Minimum [Member]

Maximum [Member]

Subsequent event [Member]

Line of Credit Facility [Line Items]

Four-year revolving credit & Term Loan agreement

19-Jan-10

Period of term loan and the revolving credit facility

'4 years

First payment on the term loan

31-Mar-10

Committed revolving credit facility

$15,000,000

$25,000,000

$15,000,000

Committed term loan

15,000,000

Revolving credit facility outstanding

Term loan requires quarterly principal payments

800,000

Frequency of payment

'Monthly

'Quarterly

Term loan final principal payment

3,000,000

SunTrust term loan, Line of credit facility, frequency of payment

'Quarterly

Index rate used as reference for interest rate on revolver and term loan

'One-month LIBOR rate

Applicable margin (percent)

2.25%

3.50%

1.75%

Revolving Credit facility and Term Loan interest rate (percent)

1.75%

1.90%

Revolving Credit facility commitment fee (percent)

0.50%

Credit facility, covenant compliance

'The SunTrust credit facility requires, as of the end of each fiscal quarter, the Company to have achieved Consolidated Adjusted EBITDA (as defined in the agreement) of at least $22.5 million for the immediately preceding four quarters. As of March 31, 2014, the Company's Consolidated Adjusted EBITDA for the preceding four quarters was $22.2 million, and therefore the Company was not in compliance with the covenant, although there were no amounts outstanding under the credit facility as of that date. On May 8, 2014, the Company entered into an amendment of the SunTrust credit facility that provided a waiver of the non-compliance with the minimum Consolidated Adjusted EBITDA covenant for the quarter ended March 31, 2014 and reduced the minimum Consolidated Adjusted EBITDA requirement to $18.0 million.

Credit facility, covenant for minimum Adjusted EBITDA

22,500,000

18,000,000

Credit facility, covenant, adjusted EBITDA, actual

22,200,000

Stock repurchase program, increase to amount authorized

10,000,000

Stock repurchase program, amount authorized

$20,000,000

Fair_Value_of_Financial_Instru1

Fair Value of Financial Instruments (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Bank Loan Obligations [Member]	'	'
Fair Value of Financial Instruments (Textual) [Abstract]	'	'
Fair value of long term debt	$0	'
Business Acquisition Obligations [Member]	'	'
Fair Value of Financial Instruments (Textual) [Abstract]	'	'
Fair value of long term debt	$0	$3.20

Income_Taxes_Details

Income Taxes (Details) (USD $)	Mar. 31, 2013
In Millions, unless otherwise specified	Mar. 31, 2013
Income Tax Disclosure [Abstract]	'
Reversed foreign income taxes accruals	$0.40

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	Mar. 31, 2014	8-May-14	8-May-14
	Sun Trust Revolving Credit Facility [Member]	Subsequent event [Member]	Subsequent event [Member]
			Sun Trust Revolving Credit Facility [Member]
Subsequent Event [Line Items]	'	'	'
Credit facility, covenant for minimum Adjusted EBITDA	$22,500,000	'	$18,000,000
Stock repurchase program, increase to amount authorized	'	10,000,000	'
Stock repurchase program, amount authorized	'	20,000,000	'
Common stock repurchased, shares	'	202,700	'
Common stock repurchased, value	'	$1,300,000	'